Related Experiment Videos
Insulin and new bone formation in diffuse idiopathic skeletal hyperostosis
Clinical Rheumatology
|September 1, 1985
Summary
Patients with diffuse idiopathic skeletal hyperostosis (DISH) often have obesity and diabetes, leading to high insulin levels. These high insulin levels may promote new bone growth in entheseal regions, causing the characteristic radiological changes of DISH.
Area of Science:
- Endocrinology
- Rheumatology
- Orthopedics
Background:
- Diffuse idiopathic skeletal hyperostosis (DISH) is associated with metabolic conditions like obesity and type 2 diabetes.
- Patients with DISH exhibit hyperinsulinemia, particularly after glucose challenges.
- Entheseal regions are susceptible to mechanical forces and are sites of new bone formation in DISH.
Purpose of the Study:
- To investigate the hypothesis that prolonged, high physiological levels of insulin contribute to new bone growth in DISH.
- To explore the role of insulin in the pathogenesis of radiological changes observed in DISH.
Main Methods:
- Review of existing literature on DISH, obesity, diabetes, and hyperinsulinemia.
- Analysis of the relationship between insulin levels and bone growth, particularly at entheseal sites.
- Correlation of proposed mechanisms with radiological findings characteristic of DISH.
Main Results:
- Elevated insulin levels, common in obese and diabetic patients with DISH, are implicated in promoting bone formation.
- High physiological insulin levels may stimulate osteogenesis in entheseal regions.
- This insulin-driven new bone growth is hypothesized to underlie the radiological manifestations of DISH.
Conclusions:
- Hyperinsulinemia, linked to obesity and diabetes, is a potential driver of new bone formation in DISH.
- Insulin's role in promoting entheseal bone growth offers a mechanistic explanation for DISH development.
- Further research is warranted to confirm the direct causal link between insulin and DISH pathogenesis.